Table 1. Patient characteristics.
| Characteristics | N (%) |
|---|---|
| Sex, male | 34 (76%) |
| Median age | 56 years (range=36–77 years) |
| ECOG PS, 0–1 | 45 (100%) |
|
Disease status | |
| Initially metastatic | 35 (78%) |
| Recurrent | 9 (20%) |
| Locally advanced unresectable | 1 (2%) |
| HER2 positivitya | 0 |
|
Metastatic site | |
| Lymph node | 39 (87%) |
| Liver | 25 (56%) |
| Peritoneum | 18 (40%) |
| Bone | 4 (9%) |
| Others | 6 (13%) |
Abbreviations: ECOG PS=Eastern Cooperative Oncology Group Performance Status; HER2=human epidermal growth factor receptor 2.
a
Determined as immunohistochemistry 3+ or immunohistochemistry 2+/fluorescence in situ hybridisation+.